Cargando…
Bevacizumab in combination with chemotherapy for the treatment of advanced ovarian cancer: a systematic review
As increased angiogenesis has been linked with the progression of ovarian cancer, a number of anti-angiogenic agents have been investigated, or are currently in development, as potential treatment options for patients with advanced disease. Bevacizumab, a recombinant monoclonal antibody against vasc...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033616/ https://www.ncbi.nlm.nih.gov/pubmed/24864163 http://dx.doi.org/10.1186/1757-2215-7-57 |